Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113831242A reveals a room-temperature synthesis route for Dolutegravir intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN1231481C details an improved process for antidiabetic intermediates, replacing expensive Pd/C with Raney Nickel to achieve significant cost reduction in API manufacturing.
Patent CN1720228A details a novel acetate salt method for enriching Z-oxime intermediates, enhancing yield and purity for reliable pharmaceutical intermediates supply chains.
Patent CN108558972A enables high-yield diosmin production. Reduces costs and ensures supply continuity for pharmaceutical intermediates manufacturing globally.
Patent CN114539077B reveals a novel asymmetric epoxidation route for levosalbutamol hydrochloride. Achieve high purity and scalable supply chain reliability.
Novel one-step synthesis of neuroprotective pyrimidines from isoflavones. High yields, mild conditions, and scalable process for pharmaceutical manufacturing.
Novel AIE photosensitizer patent CN117186055A offers high ROS generation and mitochondrial targeting for PDT drug manufacturing supply chain.
Patent CN1823074A details a chromatography-free route for bicyclic heteroaryl aldehydes. Discover cost-effective manufacturing and high-purity pharmaceutical intermediates.
Novel Lewis acid catalyzed route ensures >99.9% purity and scalable production for global pharmaceutical supply chains seeking cost efficiency.
Patent CN103724250A details a high-purity synthesis of (S)-oxiracetam using ion exchange purification, offering significant cost reduction and supply chain reliability for pharma manufacturers.
Novel non-thiazolidinedione insulin sensitizers offering improved safety profiles and scalable synthetic routes for pharmaceutical manufacturing.
Patent CN107522585B details a mild transfer hydrogenation method for quinoline resolution. Achieves 99% ee with organocatalysis, offering cost-effective and scalable chiral intermediate manufacturing.
Novel catalytic oxidation method ensures high purity and safety for omeprazole intermediates. Delivers significant supply chain stability and cost efficiency for global API manufacturing.
Patent CN105622544A details a one-step Rh-catalyzed route to N-sulfonyl-3,4-dihydro-2H-1,4-thiazine, offering streamlined manufacturing and high purity for pharmaceutical intermediates.
Patent CN1805920A details a scalable route for HCV protease inhibitor intermediates using TEMPO oxidation and mild hydration, ensuring high purity and supply chain reliability.
Novel patent CN106083837B offers safer oxazolidinone synthesis. Avoids azides, reduces steps, ensures high purity for reliable pharmaceutical intermediate supply chains.
Patent CN114736315B details a novel one-pot synthesis for lentinan core fragments. This route eliminates toxic allyl protection, offering cost reduction in API manufacturing and reliable supply.
Patent CN1054980A details chiral synthesis of 3-amino-4-methylpyrrolidine derivatives from natural amino acids, enabling high-purity quinolone antibiotic production with improved supply chain stability.
Patent CN105646373B offers green synthesis. Reduces waste, improves yield. Reliable pharma intermediate supplier.
Patent CN1656077A reveals a novel Julia-Kocienski route for statin intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.